Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered sales of equity securities and use of proceeds
Issuer purchases of equity securities
The following table presents information with respect to HealthEquity's repurchases of common stock during the three months ended April 30, 2025 (in thousands, except average price paid per share).
Period Total number of shares purchased (1) Average price paid per share (2) Total number of shares purchased as part of publicly announced plans or programs Approximate dollar value of shares that may yet be purchased under the plans or programs
February 1 - 28 5 $ 103.89 5 $ 177,240
March 1 - 31 228 $ 92.24 228 $ 156,243
April 1 - 30 469 $ 82.73 469 $ 117,483
Total 702 702
(1) Repurchases may be effected through open market purchases, privately negotiated transactions or otherwise, including through Rule 10b5-1 plans. See Note 9—Stockholders' equity for additional information related to our stock repurchase program.
(2) Average price paid per share includes costs associated with the repurchases.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.